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Suprarenal aortic clamping and reperfusion
decreases medullary and cortical blood flow by
decreased endogenous renal nitric oxide and
PGE2 synthesis
Stuart I. Myers, MD, FACS, Li Wang, BS, Fang Liu, BS, and Lori L. Bartula, BS, Richmond, VA
Objective: This study examined the hypothesis that clamping the aorta above the superior mesenteric artery (SMA)
followed by suprarenal aortic clamping and reperfusion (SRACR) decreases microvascular blood flow by loss of
endogenous medullary and cortical nitric oxide (NO) and prostaglandin (PG) E2 synthesis.
Study Design: Anesthetized male Sprague-Dawley rats (350 g) had either microdialysis probes or laser Doppler fibers
inserted into the renal cortex to a depth of 2 mm and into the renal medulla at 4 mm. Laser Doppler blood flow was
continuously monitored (data reported as percentage of change compared to basal), and the microdialysis probes were
connected to a syringe pump and perfused in vivo at 3L/min with lactated Ringer solution. Dialysate fluid was collected
at basal time zero, following 30 minutes of suprarenal aortic clamping (ischemia) followed by 60 minutes of reperfusion
and compared to a sham operation. Both groups were treated with saline carrier, indomethacin (INDO) (10 mg/kg, a
cyclooxygenase [COX] inhibitor), NG-nitro-L-arginine methyl ester (L-NAME) (20 mg/kg, a NO synthase [NOS]
inhibitor), or L-arginine (200 mg/kg, an NO precursor). Dialysate was analyzed for total NO (M) and PGE2 (pg/mL)
synthesis. The renal cortex and medulla were analyzed for inducible NOS (iNOS) and COX-2 content by Western blot.
All data are reported as mean  SEM, N > 5 and analyzed by analysis of variance.
Results: SRACR caused a marked decrease in medullary and cortical blood flow with a concomitant decrease in
endogenous medullary and cortical NO synthesis. Treatment with L-NAME further decreased blood flow and NO
synthesis in the medulla and cortex. L-Arginine restored medullary and cortical NO synthesis and blood flow in the cortex
but not the medulla. SRACR did not alter renal medullary or cortical PGE2; however, addition of INDO, COX inhibitor,
caused a concomitant decrease in medullary and cortical PGE2 synthesis and blood flow.
Conclusions: NO is an important endogenous renal vasodilator that, when maintained can help preserve cortical blood flow
following SRACR. These data also suggest that avoidance of COX-2 inhibitors can help maintain endogenous renal cortical
and medullary PGE2 synthesis and thus contribute to maintaining normal blood flow. (J Vasc Surg 2005;42:524-31.)
Clinical Relevance: This study is the first to combine in vivo physiologic assays to simultaneously identify clinically
relevant intrarenal vasodilators (cortical and medullary) that are required to maintain microvascular blood flow.
Identification of endogenous renal cortical and medullary vasodilators responsible for maintaining renal microvascular
blood flow will allow development of treatment strategies to preserve these vasodilators following SRACR. Successful
preservation of endogenous intrarenal vasodilators will help maintain renal microvascular blood flow and renal function
in the treatment of complex aortic pathology that requires SRACR.Over the past 30 years, considerable progress has been
made in the management of patients undergoing suprare-
nal aortic reconstructive surgery. Despite these advances,
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524renal dysfunction continues to be a frequent complication
of suprarenal aortic reconstruction.1-3 The pathophysiol-
ogy of renal azotemia following clamping of the aorta
above the superior mesenteric artery (SMA) followed by
suprarenal aortic clamping and reperfusion (SRACR) is not
well understood. Several animal models have shown de-
creases in renal blood flow, glomerular filtration rate
(GFR), urine flow, and fractional sodium reabsorption and
an increase in renal vascular resistance following SRACR. 4-6
The mechanisms of these alterations in renal function
following SRACR are not known. Nitric oxide (NO)7-13
and prostaglandin (PG) E2 and PGI2 (vasodilator eico-
sanoids)14-18 have been proposed as important endoge-
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renal microvascular bed and maintenance of renal blood
flow. Loss of endogenous NO or vasodilator eicosanoids
have been associated with renal vasoconstriction following
infrarenal aortic clamping and reperfusion and renal isch-
emia/reperfusion injury.19-26
There is no literature regarding the effects of SRACR
on regional blood flow or endogenous renal eicosanoid and
NO synthesis within the kidney. This study examined the
hypothesis that SRACR decreases microvascular blood flow
by loss of endogenous medullary and cortical NO and
PGE2 synthesis.
MATERIAL AND METHODS
Animal model. All animal surgery and care were per-
formed using the established guidelines approved by the
Institutional Animal Care and Use Committee, Virginia
Commonwealth University/Medical College of Virginia
and theMcGuire VAMedical Center, Richmond, Va. Male
Sprague-Dawley rats (350 g; Harlan, Indianapolis, Ind)
were anesthetized with 2% isoflurane vaporized (oxygen-
ated) by oxygen. The rats were placed on a small animal
operating table with fixed bar clamps for precise placement
of microdialysis catheters or placement of micropositioners
for two laser fiber probes. The right femoral artery was
cannulated, heparinized (100 U/kg), and connected to a
blood pressure analyzer (BPA; Digimed, Louisville, Ky).
Perivascular ultrasonic blood flow probes (Transonic Sys-
tems, Inc., Ithaca, NY) were placed around the renal artery,
and the abdominal aorta and data were collected as millili-
ters per minute. Body temperature was monitored via rectal
temperature probe. The animal’s abdomen was filled with
saline and lubricating jelly to insulate contact between
blood flow probes and blood vessels. Both themicrodialysis
group and the laser Doppler group were treated with saline
carrier, indomethacin (10 mg/kg, a cyclooxygenase [COX]
inhibitor), L-NAME (NG-nitro-L-arginine methyl ester)
(20 mg/kg, an NO synthase [NOS] inhibitor), or L-argi-
nine (200 mg/kg, an NO precursor).21,27 The renal cortex
and medulla from the left kidney were separated and ana-
lyzed for inducible NOS (iNOS) and COX-2 content by
Western blot (see below).
Microdialysis probes in vivo perfusion. Microdialysis
probes were prepared in advance to allow curing of the
epoxy and glue used to connect segments of PE-50 tubing,
PE-10 tubing (Becton Dickinson, Sparks, Md), flexible
fused silica tubing (Polymicro Technologies, Phoenix,
Ariz), microdialysis tubing (13-kd transmembrane diffusion
cutoff tubing) (Spectrum Laboratories, Rancho Domin-
quez, Calif), and additional flexible fused silica tubing.28-30
One microdialysis probe was inserted into the renal cortex
to a depth of 2 mm and another into the renal medulla at 4
mm. These probes were connected to a syringe pump and
perfused at a rate of 3 L/min with lactated Ringer solution.
Dialysate fluid was collected at basal time zero, following
30 minutes of suprarenal aortic clamping (ischemia) fol-
lowed by 60 minutes of reperfusion and compared to a
sham (SH) operation. Dialysate samples were collected andfrozen at 80°C until assayed for NO and PGE2. Use of
the microdialysis probes allowed NO and PGE2 to diffuse
in and out of the dialysis probe depending on the local
concentration. As NO and PGE2 are not stored within the
cell, release of these substances represent de novo synthesis.
After completion of each experiment, the kidneys were
reopened to confirm accurate placement of the microdialy-
sis probes.
Laser Doppler renal cortical and medullary blood
flow analysis. The right kidney was isolated and placed in
a 21-mm Lucite kidney cup. Ultrasonic blood flow probes
(Transonic Systems, Inc.) were placed around the renal
artery and abdominal aorta, and data were collected in
milliliters per minute. Body temperature was monitored via
rectal probe. Micropositioners were used to insert the
shallow (2 mm cortical) and deep (4 mm medullary) cali-
brated laser fiber probes. The position of the fibers within
the kidneys was checked after each experiment. A Periflux
4001 Dual Channel Laser Doppler flowmeter (Perimed,
Järfälla, Sweden) was used to evaluate microvascular perfu-
sion. Measurements were expressed as arbitrary perfusion
units. The perfusion units represent the product of the
velocity and the concentration of moving blood cells within
the measuring volume. After a 5-minute equilibration pe-
riod, basal readings were recorded and subsequent readings
recorded every 10minutes throughout the ischemia/reper-
fusion and sham procedures.22-25
Enzyme immunoassays.19 The renal microdialysis ef-
fluent was frozen at 80°C until assayed for PGE2 by an
immunoassay kit (Cayman Chemical, Ann Arbor, Mich).
Samples were run in duplicate and reported as picograms of
PGE2 per milliliter (mean  SEM).
31
NO analysis. A Sievers 280 NOA Nitric Oxide Ana-
lyzer with Radical Purger (Sievers Instruments, Boulder,
Colo) was used to detect NO (M) and its reaction products
in biologic samples. The technique used for the measure-
ment of NO and its oxidation products was the reduction of
nitrate, nitrite, and nitrosothiols using vanadium (III) and
hydrochloric acid at 90°C. Data are reported as M.
Protein assays. The kidneys were harvested and
placed on ice. Cortical and medullary tissue were rapidly
separated, frozen in liquid nitrogen, and stored at 80°C
until assayed for protein. Total protein was determined by
the Bradford method31 using the Bio-Rad protein assay dye
reagent concentrate (Bio-Rad Laboratories, Hercules, Calif).
A 5X SDS sample buffer (1X 62.5 mmol/L Tris-HCl, pH
8.0; 2% sodium dodecyl-sulfate (SDS); 0.025% bromophe-
nol blue; 20% glycerol; 5% -mercaptoethanol) was added
to the protein samples and stored at80°C until assayed by
Western blot.
SDS-polyacrylamide gel electrophoresis/Western
blot analyses. Protein samples diluted in SDS sample
buffer were solubilized by boiling for 4 minutes. Ali-
quots (25 g) were loaded into gel lanes of a vertical
electrophoretic unit (Bio-Rad), and protein separation
by molecular weight was carried out on 1-mm 7% poly-
acrylamide resolving gel with a 1-mm 3% stacking gel by
the Laemmli method,32 which includes prestained mo-
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then transferred from the resolving gels to nitrocellulose
membranes (Schleicher & Schuell, Keene, NH) as de-
scribed by Burnette33 using a Trans-Blot electrophoretic
transfer cell (Bio-Rad) operating at 100 mA for 18 hours
at 40°C. The membranes were incubated for 1 hour at
room temperature in blocking buffer (buffer B: 10
mmol/L sodium phosphate, 0.5 mol/L NaCl, 10% bo-
vine serum albumin, 0.05% Tween 20) and subsequently
overnight at room temperature in buffer B containing a
primary antibody,19,34  -COX-2 polyclonal antiserum
(Cayman Chemical Co.), or -iNOS antiserum (Oxford
Biodmedical Research, Inc., Oxford, Mich). The nitro-
cellulose membranes were then washed of excess primary
antibody at room temperature in phosphate-buffered sa-
line Tween buffer (PBST: 10mmol/L potassium phosphate,
pH 7.4, 0.9% sodium chloride, 0.05% Tween 20) and
incubated for 1 hour at room temperature in buffer B and
secondary antibody, goat “-mouse IgG horseradish perox-
idase (Bio-Rad). The membranes were washed of second-
ary antibody at room temperature in PBST, incubated in
chemiluminescence reagent (Renaissance; DuPont-NEN,
Boston, Mass) for 1 minute, inserted into a plastic sheet
protector, bubbles removed, and placed against autora-
diography film (Kodak, Rochester, NY). The film exposure
times were adjusted to obtain the ideal density of bands
identifying the enzymes of interest, and an imaging system
(Alpha Innotech, San Leandro, Calif) was used to measure
these bands by spot densitometry.
Creatinine clearance. Separate groups of animals
were used to measure serum creatinine, urine creatinine,
and urine volume. These groups underwent the same
supra-SMA aortic clamping (and SH) followed by reperfu-
Fig 1. The effect of suprarenal aortic clamping and reperfusion
on heart rate. The heart rate was continuously monitored at basal
time period, during 30 minutes of suprarenal aortic clamping
(ischemia) followed by 60 minutes of reperfusion and compared to
a sham operation. Both groups were treated with either saline
carrier (ischemia/reperfusion [IR] group, N 10), indomethacin
(Indo) (10mg/kg [IR Indo, N 9], cyclooxygenase inhibitor),
NG-nitro-L-arginine methyl ester (L-NAME) (20 mg/kg, nitric
oxide synthase inhibitor, N  5), or L-arginine (L-Arg) (200
mg/kg, nitric oxide precursor, N  7). Data are reported as beats
per minute and expressed as mean  SEM.sion as the above groups but without placement of micro-dialysis probes or laser Doppler fibers placed in the kidneys.
These groups were subjected to the SRACR model with
and without indomethacin, L-NAME or L-arginine as de-
scribed above. Serum and urinary creatinine were measured
by a SYNCHRON LC System (Beckman Coulter Inc.,
Fullerton, Calif).
Statistical analysis. Data are expressed as mean 
SEM. Analysis of variance and Student’s t tests were used to
determine differences among the groups. P .05 value was
considered statistically significant.
RESULTS
SRACR did not alter heart rate compared to the SH
group. Treatment of the SRACR or SH groups with indo-
methacin, L-NAME of L-arginine did not alter heart rate as
well (Fig 1). SRACR decreased blood pressure slightly
compared to the SH group. As expected, L-NAME in-
creased blood pressure and L-arginine decreased blood
pressure compared to the baseline predrug measurements
(Fig 2).
Suprarenal aortic clamping for 30 minutes markedly
decreased both cortical and medullary blood flow. Follow-
ing reperfusion for 60 minutes, cortical and medullary
blood flow was still significantly decreased compared to
basal levels, but the decrease was lessened by 50% compared
to the 30-minute ischemia period (Figs 3 and 4). Treat-
ment of the animals with either indomethacin or L-NAME
during SRACR significantly decreased cortical and medul-
lary blood flow following reperfusion compared to the
ischemia/reperfusion group without drug treatment.
Fig 2. The effect of suprarenal aortic clamping and reperfusion
on mean blood pressure. The mean blood pressure was continu-
ously monitored at basal time period, during 30 minutes of supra-
renal aortic clamping (ischemia) followed by 60 minutes of reper-
fusion and compared to a sham operation. Both groups were
treated with either saline carrier (ischemia/reperfusion [IR]
group, N  10), indomethacin (Indo) (10 mg/kg [IR  Indo, N
 9], cyclooxygenase inhibitor), NG-nitro-L-arginine methyl ester
(L-NAME) (20 mg/kg, nitric oxide synthase inhibitor, N 5), or
L-arginine (L-Arg) (200 mg/kg, nitric oxide precursor, N  7).
Data are reported as mm Hg and expressed as mean  SEM. a
indicates significance at P  .05 compared to sham; b indicates
significance at P  .05 compared to the IR group without drug
treatment; c indicates significance at P  .05 compared to the
L-NAME group. BF, blood flow.
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significantly lessened the decrease in cortical and medullary
blood flow following reperfusion compared to the isch-
emia/reperfusion and L-NAME groups (Figs 3 and 4). In
fact, L-arginine pretreatment almost completely reversed
the decrease in medullary blood flow to basal (prior to
placement of the aortic clamp) levels following reperfusion
(Fig 4).
Suprarenal aortic clamping for 30 minutes led to a
profound decrease in cortical and medullary NO release
when compared to the SH level. Both cortical and med-
ullary NO release was restored somewhat toward the SH
level following 60 minutes of reperfusion (Figs 5 and 6).
Treatment of the animals with L-NAME did not signifi-
cantly alter the low cortical or medullary NO release that
was present following SRACR in the ischemia/reperfu-
sion group (treated with carrier only). L-Arginine pre-
treatment restored cortical NO release to the SH level
following SRACR but did not restore medullary NO
release to SH levels following SRACR (Figs 5 and 6).
Suprarenal aortic clamping for 30 minutes did not
significantly alter cortical or medullary PGE2 release fol-
lowing suprarenal aortic clamping or reperfusion when
compared to the SH level. Both cortical and medullary
PGE2 release was significantly decreased to very low levels
following SRACR and pretreatment with indomethacin
(Figs 7 and 8).
SRACR did not alter iNOS content in the cortex but
did induce a significant decrease in iNOS content in the
medulla. SRACR did not alter COX-2 content in the cortex
Fig 3. The effect of suprarenal aortic clamping and reperfusion
on renal cortical blood flow. Laser Doppler probes were placed 2
mm into the cortex and blood flow (BF) was continuously moni-
tored at basal time period, during 30 minutes of suprarenal aortic
clamping (ischemia) followed by 60 minutes of reperfusion and
compared to a sham operation. Both groups were treated with
either saline carrier (ischemia/reperfusion [IR] group, N  10),
indomethacin (Indo) (10 mg/kg [IR  Indo, N  9], cyclooxy-
genase inhibitor), NG-nitro-L-arginine methyl ester (L-NAME)
(20 mg/kg, nitric oxide synthase inhibitor, N  5), or L-arginine
(L-Arg) (200 mg/kg, nitric oxide precursor, N  7). Data are
reported as the percentage of change from basal time zero and
expressed as mean  SEM. a indicates significance at P  .05
compared to sham; b indicates significance at P .05 compared to
the IR group without drug treatment; c indicates significance at P
 .05 compared to the L-NAME group.or medulla (Fig 9).SRACR caused a marked decrease in the creatinine
clearance compared to the SH group. Treatment with
indomethacin, L-NAME, or L-arginine did not alter creat-
inine clearance following SRACR (Fig 10).
DISCUSSION
Over the past several decades considerable progress has
been made in the management of patients undergoing
suprarenal aortic reconstructive surgery. Despite these ad-
vances, renal dysfunction continues to be a frequent com-
plication of suprarenal aortic reconstruction. Giulini et al1
examined their results in 7534 consecutive patients treated
with elective abdominal aortic aneurysm surgical repair
from 1992 to 1999. Of this group, 56 patients had juxta-
renal aneurysms that required suprarenal aortic clamping.
The average time of renal exclusion was 20 minutes in the
group treated with suprarenal aortic clamping. Renal func-
tion deteriorated in eight (14%) of the suprarenal group
compared to none in group treated with infrarenal aortic
clamping. Only one of the eight patients with renal deteri-
oration required permanent dialysis.
Whalber et al2 reviewed 60 consecutive patients be-
tween 1987 and 1994 who were treated for an abdomi-
nal aortic aneurysm or aortic occlusive disease that re-
quired temporary suprarenal aortic clamping during the
aortic reconstruction. In this excellent series, none of the
surviving patients required dialysis, but transient
azotemia occurred in 23% of the patients. Odds ratios for
the transient renal function showed a 10-fold increased
risk of renal dysfunction when the suprarenal aortic
Fig 4. The effect of suprarenal aortic clamping and reperfusion
on renal medullary blood flow. Laser Doppler probes were placed
4 mm into the medulla and blood flow (BF) was continuously
monitored at basal time period, during 30 minutes of suprarenal
aortic clamping (ischemia) followed by 60 minutes of reperfusion
and compared to a sham operation. Both groups were treated with
saline carrier (ischemia/reperfusion [IR] group, N  10), indo-
methacin (Indo) (10 mg/kg [IR  Indo, N  9], cyclooxygenase
inhibitor), NG-nitro-L-arginine methyl ester (L-NAME) (20 mg/
kg, nitric oxide synthase inhibitor, N  5), or L-arginine (L-Arg)
(200 mg/kg, nitric oxide precursor, N  7). Data are reported as
the percentage of change from basal time zero and expressed as
mean  SEM. a indicates significance at P  .05 compared to
sham; b indicates significance at P .05 compared to the IR group
without drug treatment; c indicates significance at P  .05 com-
pared to the L-NAME group.
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in the best of surgical series, aortic reconstruction requir-
ing suprarenal aortic clamping continues to be compli-
cated by the potential for subsequent loss of renal func-
tion following SRACR.
The pathophysiology of renal azotemia following
SRACR is not well understood. Very few experimental
studies have examined the effect of SRACR on renal
blood flow and function. Several animal models have
shown that suprarenal aortic clamping decreases renal
blood flow, GFR, urine flow, and fractional sodium
reabsorption and an increase in renal vascular resistance
following SRACR.4-6 Mitaka et al4 studied the effects of
1.5 hours of SRACR on canine renal function. The
animals subjected to SRACR demonstrated a decrease in
urine volume, renal blood flow, and creatinine clearance.
These SRACR-induced decreases in renal function were
reversed by prior treatment with atrial natriuretic pep-
tide, suggesting that this protein may be helpful in
protecting renal function following ischemia/reperfu-
sion injury.4 Another group of studies has shown that
endothelin contributes to decreased renal blood flow,
GFR, urine flow, fractional sodium, and an increase in
renal vascular resistance following SRACR.5,6 Unfortu-
nately, none of these studies examined the effect of
SRACR on the anatomic distribution and patterns of
synthesis of endogenous renal vasodilators and the sub-
sequent role of these changes on renal blood flow and
function.
Endogenous renal prostanoids have been hypothesized
Fig 5. The effect of suprarenal aortic clamping and reperfusion
on renal cortical nitric oxide (NO) release. Microdialysis probes
were placed 2 mm into the cortex, connected to a syringe pump,
and perfused in vivo at 3 L/min with lactated Ringer solution.
Dialysate fluid was collected at basal time zero, following 30
minutes of suprarenal aortic clamping (ischemia) followed by 60
minutes of reperfusion and compared to a sham operation. Both
groups were treated with saline carrier (ischemia/reperfusion [IR]
group, N  10), indomethacin (Indo) (10 mg/kg [IR  Indo, N
 9], cyclooxygenase inhibitor), NG-nitro-L-arginine methyl ester
(L-NAME) (20 mg/kg, NO synthase inhibitor, N  5), or L-
arginine (L-Arg) (200 mg/kg, NO precursor, N  7). Data are
reported as mol/L and expressed as mean  SEM. a indicates
significance at P  .05 compared to sham; b indicates significance
at P  .05 compared to the IR group without drug treatment; c
indicates significance at P .05 compared to the L-NAME group.to be potent mediators of renal vascular resistance for morethan 30 years.14-20 PGE2 has been shown to be the major
renal prostanoid synthesized by the kidney, although the
kidney can also synthesize significant levels of PGI2. Both
of these arachidonic acid metabolites are potent vasodila-
tors and the decreased synthesis of renal PGE2 and PGI2
has been associated with renal vasoconstriction.15-20 The
loss of endogenous renal vasodilators has been shown fol-
lowing a number of injuries including renal ischemia/
reperfusion injury,18-21 intestinal ischemia/reperfusion in-
jury,19,35,36 and acute burn.37,38 In contrast to acute
injury, the kidney responds to many types of chronic inju-
ries (hydronephrosis, elevated renal venous pressure, isch-
emia) by altering endogenous eicosanoid prostanoid re-
lease to reflect a net increase in the synthesis of the potent
vasoconstrictor thromboxane A2.
16,17 In one example, 72
hours of hydronephrosis profoundly increased the endog-
enous synthesis and release of thromboxane in the renal
cortex. The authors of this study hypothesized that the
increased release of cortical thromboxane was involved with
regulation of cortical blood flow during this injury. Thus,
increased vasoconstrictor eicosanoid release can contribute
to decreased renal blood flow following chronic renal in-
jury.16,17
The continuous basal release of NO within the renal
microvasculature has been shown to contribute to the
maintenance of normal renal blood flow and function
under normal physiologic conditions.7-13 Loss of renal
NO synthesis has been suggested to contribute to renal
vasoconstriction following renal ischemia/reperfusion
injury.7-13,20,21,39 Renal ischemia in the rat increased
renal vascular resistance, which could be reversed with
Fig 6. The effect of suprarenal aortic clamping and reperfusion
on renal medullary nitric oxide (NO) release. Microdialysis probes
were placed 4 mm into the medulla, connected to a syringe pump,
and perfused in vivo at 3 L/min with lactated Ringer solution.
Dialysate fluid was collected at basal time zero, following 30
minutes of suprarenal aortic clamping (ischemia) followed by 60
minutes of reperfusion and compared to a sham operation. Both
groups were treated with saline carrier (ischemia/reperfusion [IR]
group, N  10), indomethacin (Indo) (10 mg/kg [IR  Indo, N
 9], cyclooxygenase inhibitor), NG-nitro-L-arginine methyl ester
(L-NAME) (20 mg/kg, nitric oxide synthase inhibitor, N 5), or
L-arginine (L-Arg) (200 mg/kg, NO precursor, N  7). Data are
reported as mol/L and expressed as mean  SEM. a indicates
significance at P  .05 compared to sham; b indicates significance
at P  .05 compared to the IR group without drug treatment; c
indicates significance at P .05 compared to the L-NAME group.
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Depletion of renal arginine led to was show to decrease
renal perfusion rate, GFR, and urine flow rate, which
could be completely reversed with L-arginine (not D-
arginine) repletion. These results suggested that L-argi-
nine was an important amino acid in the regulation of
renal NO synthesis and renal function.10 A more recent
study used micropuncture techniques in the rat to exam-
ine the role of NO in glomerular arteriolar microvascular
blood flow and renal function. The results showed that
intravenous L-NG-monomethyl-L-arginine (an NOS in-
hibitor) caused glomerular arteriolar vasoconstriction
(with a predominant effect on the efferent arteriole),
decreased ultrafiltration, and increased glomerular capil-
lary pressure.11,12
A study quite relevant to the present study compared
the effect of NOS inhibition on renal function in the in vitro
and in vivo perfused rat kidney models. In the experiments
using the in vitro perfused rat kidney, NOS inhibition
caused an increase in renal vascular resistance that was
reversed by L-arginine infusion. In the experiments using
the in vivo kidney, NOS inhibition increased systemic arte-
rial pressure, decreased GFR, and decreased renal plasma
flow.13 Zou and Cowley39 used an in vivo microdialysis
technique to determine regional differences of renal NO
production. These authors found that there was a higher
NO concentration in the medulla than the cortex. The
authors concluded that NOmay play a role in the control of
Fig 7. The effect of suprarenal aortic clamping and reperfusion
on renal cortical prostaglandin E2 (E2) release. Microdialysis
probes were placed 2 mm into the cortex, connected to a syringe
pump, and in vivo at 3 L/min with lactated Ringer solution.
Dialysate fluid was collected at basal time zero, following 30
minutes of suprarenal aortic clamping (ischemia) followed by 60
minutes of reperfusion and compared to a sham operation. Both
groups were treated with saline carrier (ischemia/reperfusion [IR]
group, N  10), indomethacin (Indo) (10 mg/kg [IR  Indo, N
 9], cyclooxygenase inhibitor), NG-nitro-L-arginine methyl ester
(L-NAME) (20 mg/kg, nitric oxide synthase inhibitor, N 5), or
L-arginine (L-Arg) (200 mg/kg, nitric oxide precursor, N  7).
Data are reported as pg/mL PGE2 release and is expressed as mean
 SEM. a indicates significance at P  .05 compared to sham; b
indicates significance at P .05 compared to the IR group without
drug treatment; c indicates significance at P .05 compared to the
L-NAME group.vascular tone and tubular function in the renal medulla.Although these studies suggest that NO is an important
endogenous renal vasodilator in the maintenance of renal
blood flow, the effect of SRACR on renal cortical and
medullary NO synthesis has remained undefined.
Several studies have examined the hypothesis that
renal ischemia decreases renal blood flow and endoge-
Fig 8. The effect of suprarenal aortic clamping and reperfusion
on renal medullary prostaglandin E2 (E2) release. Microdialysis
probes were placed 2 mm into the cortex, connected to a syringe
pump, and in vivo at 3 L/min with lactated Ringer solution.
Dialysate fluid was collected at basal time zero, following 30
minutes of suprarenal aortic clamping (ischemia) followed by 60
minutes of reperfusion and compared to a sham operation. Both
groups were treated with saline carrier (ischemia/reperfusion [IR]
group, N  10), indomethacin (Indo) (10 mg/kg [IR  Indo, N
 9], cyclooxygenase inhibitor), NG-nitro-L-arginine methyl ester
(L-NAME) (20 mg/kg, nitric oxide synthase inhibitor, N 5), or
L-arginine (L-Arg) (200 mg/kg, nitric oxide precursor, N  7).
Data are reported as pg/mL PGE2 release and expressed as mean
 SEM. a indicates significance at P  .05 compared to sham; b
indicates significance at P .05 compared to the IR group without
drug treatment; c indicates significance at P .05 compared to the
L-NAME group.
Fig 9. The effect of suprarenal aortic clamping and reperfusion
on renal cortical and medullary inducible nitric oxide synthase
(iNOS) and cyclooxygenase 2 (COX-2) content. Protein from
renal cortex and medulla was prepared from sham and suprarenal
aortic clamping and reperfusion animals and subjected to Western
blot analysis to identify content of iNOS and COX-2. The blots
were analyzed by densitometry. Data are expressed as densitometry
units SEM (N 8). a indicates significance at P .05 compared
to sham.
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study showed that inhibition of either NO synthesis or
COX enhanced the increase in renal vascular resistance
following renal ischemia and reperfusion. The authors
concluded that vasodilator eicosanoids and NO are im-
portant mediators involved with maintenance of renal
blood flow after ischemia/reperfusion injury.20 A second
group of studies suggest that acute renal injury induces
changes in blood flow away from the deep cortex and
outer medulla.16,17,22-26 There is no literature regarding
the effects of SRACR on regional blood flow in the
kidney.
The current study is the first to use both in vivo
microdialysis and microlaser Doppler fibers to investi-
gate in vivo real-time changes in renal cortical and med-
ullary blood flow, NO, and PGE2 synthesis following
SRACR. In the present study, temporary occlusion of the
abdominal aorta above the SMA caused a marked de-
crease in medullary and cortical blood flow with a con-
comitant decrease in endogenous medullary and cortical
NO synthesis. Treatment with L-NAME (NOS inhibi-
tor) further decreased blood flow and NO synthesis in
the medulla and cortex. L-Arginine restored medullary
and cortical NO synthesis and blood flow in the cortex
(but not the medulla). SRACR did not alter renal med-
ullary or cortical release of PGE2. However, the addition
of indomethacin, a COX inhibitor, caused a concomitant
decrease in medullary and cortical PGE2 synthesis and
blood flow. The Western blot data suggest that the loss
of endogenous cortical NO could contribute to the
Fig 10. The effect of suprarenal aortic clamping and reperfusion
on creatinine clearance. Serum and urine were collected from
separate groups of animals to measure serum creatinine, urine
creatinine, and urine volume to calculate creatinine clearance. The
serum and urine were collected at the time zero of each experiment
and at the end of reperfusion. These groups underwent the same
above the superior mesenteric artery aortic clamping (and sham)
followed by reperfusion without drug treatment (ischemia/reper-
fusion [IR], N  8), treatment with indomethacin (Indo) (IR 
Indo, N  5), treatment with NG-nitro-L-arginine methyl ester
(L-NAME) (IR  L-NAME, N  6), and treatment with L-
arginine (L-Arg) (IR  L-Arg, N  5). Data are reported as
mL/min and expressed as mean SEM. a indicates significance at
P  .05 compared to sham.decreased cortical blood flow found following theSRACR model and may be one of the mechanisms that
contribute to increased cortical vascular resistance fol-
lowing renal injury. The creatinine clearance data sug-
gest that even our model of short-term SRACR induced
a profound decrease in renal function that was not
reversed by treatment with the NO precursor L-arginine.
This finding suggests that there are other factors that
contribute to decreased renal function following SRACR
and that our future studies should determine the earliest
time period of SRACR in which reversing the decrease in
renal cortical and medullary blood flow will still maintain
normal renal function.
In summary, the findings of this study suggest that
NO is an important endogenous renal vasodilator that,
when maintained, can help preserve cortical blood flow
following SRACR. The data in Figures 6 and 9 suggest
that the downregulation of in vivo microdialysis renal
medullary NO release following SRACR was due in part
to a decrease in cortical iNOS content. Interestingly,
these data also suggest that avoidance of COX inhibitors
can help maintain endogenous renal cortical and medul-
lary PGE2 synthesis and thus contribute to maintaining
normal blood flow following SRACR injury. Identifica-
tion of factors responsible for maintaining renal micro-
vascular blood flow will allow development of treatment
strategies that will help maintain renal microvascular
blood flow and function in the treatment of complex
aortic pathology that requires suprarenal aortic clamping
during the aortic reconstruction.
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